August 18, 2025

Melrose Industries Plc appoints Guy Hachey as Non-Executive Director

Melrose Industries has appointed aerospace industry veteran Guy Hachey to its Board as Non-executive Director. Hachey brings over 30 years of leadership experience from Bombardier Aerospace, Delphi, and Advent International, and currently serves as a director at Hexcel Corporation...

Landsec sells Queen Anne’s Mansions office block for £245m

Landsec has agreed the £245m unconditional sale of its Queen Anne’s Mansions office block in SW1 to Arora Group. The deal, which crystallises redevelopment value and delivers an immediate uplift to return on equity, marks early progress towards Landsec’s plan to release £2bn from offices by 2030...

HICL Infrastructure Plc agrees £225m sale of seven UK PPP assets

HICL has agreed to sell a portfolio of seven UK PPP assets to APG for around £225m, in line with its March 2025 valuation. Proceeds will support the £150m share buyback programme and meet outstanding equity commitments, bringing total disposals over the past two years to about £725m at strong valuations...

Cizzle Biotechnology to launch CIZ1B cancer test across USA

Cizzle Biotechnology has announced that its North American partner, Cizzle Bio Inc, has signed an agreement with a multi-site accredited laboratory group to roll out the CIZ1B biomarker test for early lung cancer detection across the USA...

Great Portland Estates secures £2.5m fully managed leasing deals in London

GPE has completed three new Fully Managed leasing agreements totalling 11,720 sq ft across SIX St Andrew Street, EC4 and 31/34 Alfred Place, WC1. The deals, let to global business and technology firms including EKU Energy, will generate £2.5 million in annual rent, 2.8% ahead of the March 2025 ERV...

Aptamer secures contract Eetension with top 5 pharma partner

Aptamer has extended its collaboration with a top 5 global pharmaceutical company to advance Optimer® binders into a fully functional ELISA assay. The agreement builds on the successful completion of the initial binder development phase, with Aptamer retaining IP ownership to support future commercialisation opportunities...
Search

Funds

August 18, 2025

Melrose Industries Plc appoints Guy Hachey as Non-Executive Director

Melrose Industries has appointed aerospace industry veteran Guy Hachey to its Board as Non-executive Director. Hachey brings over 30 years of leadership experience from Bombardier Aerospace, Delphi, and Advent International, and currently serves as a director at Hexcel Corporation...

Landsec sells Queen Anne’s Mansions office block for £245m

Landsec has agreed the £245m unconditional sale of its Queen Anne’s Mansions office block in SW1 to Arora Group. The deal, which crystallises redevelopment value and delivers an immediate uplift to return on equity, marks early progress towards Landsec’s plan to release £2bn from offices by 2030...

HICL Infrastructure Plc agrees £225m sale of seven UK PPP assets

HICL has agreed to sell a portfolio of seven UK PPP assets to APG for around £225m, in line with its March 2025 valuation. Proceeds will support the £150m share buyback programme and meet outstanding equity commitments, bringing total disposals over the past two years to about £725m at strong valuations...

Cizzle Biotechnology to launch CIZ1B cancer test across USA

Cizzle Biotechnology has announced that its North American partner, Cizzle Bio Inc, has signed an agreement with a multi-site accredited laboratory group to roll out the CIZ1B biomarker test for early lung cancer detection across the USA...

Great Portland Estates secures £2.5m fully managed leasing deals in London

GPE has completed three new Fully Managed leasing agreements totalling 11,720 sq ft across SIX St Andrew Street, EC4 and 31/34 Alfred Place, WC1. The deals, let to global business and technology firms including EKU Energy, will generate £2.5 million in annual rent, 2.8% ahead of the March 2025 ERV...

Aptamer secures contract Eetension with top 5 pharma partner

Aptamer has extended its collaboration with a top 5 global pharmaceutical company to advance Optimer® binders into a fully functional ELISA assay. The agreement builds on the successful completion of the initial binder development phase, with Aptamer retaining IP ownership to support future commercialisation opportunities...
Search

Funds

August 18, 2025

FTSE 100

Funds